DOCSLIB.ORG

Healthcare & Life Sciences Update

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Healthcare & Life Sciences Update Healthcare & Life Sciences Industry Update December 2012 Member FINRA/SIPC www.harriswilliams.com What We’ve Been Reading December 2012 • An article in the New York Times by Robert Pear gives some very useful information around the tax increases that will be taking effect in January as part of the ACA. With the general media mostly focused on the fiscal cliff and the impending rises in capital gains and dividend taxes, many affluent Americans have overlooked the additional taxes they will be hit with in order to fund health reform. The article goes into some detail on the payroll, investment and income taxes that are expected to generate more than $300 billion in tax revenues over the next 10 years with 85% coming from the top 1% of taxpayers. • In order to save costs, California is currently experimenting with a program by which a large group of disabled Medicaid enrollees have been moved out of traditional fee-for- service coverage into managed care plans outsourced to commercial insurers. According to an article by Mary Carey and Sarah Varney at Medcity News, this program is being closely watched by both industry and the federal government ahead of the shift of 2 million Medicare/Medcaid dual eligibles into managed care as required by the ACA. California is expecting to save $663 million as part of the program but there is significant concern that the standard of care for these patients will suffer. • The Supreme Court is set to consider the legality of settlements between branded and generic pharmaceutical companies sometimes called “Pay for Delay” settlements, according to an article in the Wall Street Journal. These involve a branded manufacturer settling a patent litigation with a generic manufacturer by effectively making a payment in return for a delay in the release of the generic. The FTC alleges that “Pay for Delay” costs consumers $3.5 billion dollars annually. The Journal article goes into some depth in discussing this topic, which is currently a major focus of the FTC. Note: a subscription to the Wall Street Journal online is required to view this article. 1 Equity Trading Overview December 2012 Median TEV/ Median TEV/ Key Trading Number of Average Sector Enterprise Change in Stock Price LTM Multiples Forward Mulitples Companies Statistics Value ($ mm) 3 mos. 12 mos. Revenue EBITDA Revenue EBITDA (detail begins Clinical Laboratories 3 $7,834 (3.2%) (1.3%) 1.7x 7.9x 1.7x 7.8x Contract Pharma Manufacturing 5 915 10.0% 58.8% 1.3x 12.0x 1.5x 11.1x on page 6) Contract Research Organizations 5 1,801 19.4% 61.0% 1.4x 10.1x 1.3x 9.5x Disease Management 2 3,032 1.2% 22.6% 1.5x 7.9x 1.5x 8.5x Emergency Services 1 1,935 (5.8%) 35.2% 2.3x 7.7x 2.3x 7.8x Health Care Staffing 4 1,173 11.6% 59.4% 1.0x 13.4x 0.9x 11.7x HMO - Medical 11 13,848 1.6% 11.5% 0.4x 6.0x 0.4x 6.6x Support Services Information Services 11 2,194 2.8% 7.2% 2.9x 13.1x 2.9x 10.7x Specialty Managed Care 2 1,568 (2.8%) (12.4%) 0.7x 5.3x 0.7x NA Payer, Provider, & Pharmacy Specialty Pharmacy Management 5 16,649 13.2% 14.5% 0.6x 10.1x 0.8x 9.3x Dental Products 4 18,965 4.5% 18.5% 2.5x 11.4x 2.5x 10.3x Durable Medical Equipment 4 2,542 2.9% 1.1% 1.4x 7.1x 1.3x 8.1x Life Sciences Tools 3 13,701 3.4% 3.9% 2.2x 8.6x 2.2x 8.0x Devices Medical Devices and Products 14 37,645 2.0% 13.0% 2.5x 9.4x 2.5x 8.8x Products & Medical / Surgical / Dental Supplies 6 10,237 3.9% 13.3% 0.2x 7.6x 0.2x 7.4x Acute-Care Hospitals 6 13,287 10.1% 21.1% 0.9x 6.4x 0.9x 6.6x Assisted Living 7 1,742 12.7% 64.4% 1.9x 10.8x 1.7x 8.7x Diagnostic Imaging 3 2,761 (7.5%) 1.6% 1.4x 5.5x 1.6x 8.0x Dialysis Services 2 23,566 3.8% 21.2% 2.2x 10.5x 2.1x 10.2x Home Care / Hospice 6 593 (1.4%) 36.0% 0.5x 6.0x 0.5x 6.1x Long-Term Care 3 1,159 (3.2%) 7.4% 0.8x 5.8x 0.8x 5.3x Physician Practice Management 3 1,719 (4.9%) 2.0% 1.7x 8.7x 1.6x 9.8x Psychiatric Hospitals / Management 3 2,388 12.6% 12.1% 0.3x 6.0x 0.4x 5.9x Provider-Based Services Provider-Based Surgicenters / Rehabilitation 4 2,107 (1.3%) 27.3% 1.5x 7.1x 1.5x 7.3x Payer, Provider, & Pharmacy Support Services 49 $5,095 4.8% 25.7% 1.4x 9.3x 1.4x 9.2x Products & Devices 31 $16,618 3.3% 9.9% 1.8x 8.8x 1.7x 8.5x Provider-Based Services 37 $5,480 2.3% 21.4% 1.2x 7.4x 1.2x 7.5x HW&Co. HCLS Composite Index 117 $7,640 3.6% 20.8% 1.4x 8.5x 1.4x 8.4x S&P 500 1.2% 13.6% Public Company Assisted Living Sector Contract Research Organizations Health Care Staffing Performance Contract Pharma Manufacturing (12-month % Home Care / Hospice Emergency Services change in stock Surgicenters / Rehabilitation price) Disease Management Dialysis Services Acute-Care Hospitals HW&Co. HCLS Composite Index Dental Products Specialty Pharmacy Management S&P 500 Medical / Surgical / Dental Supplies Medical Devices and Products Psychiatric Hospitals / Management HMO - Medical Long-Term Care Information Services Life Sciences Tools Physician Practice Management Diagnostic Imaging Durable Medical Equipment Clinical Laboratories Specialty Managed Care (30.0%) (20.0%) (10.0%) 0.0% 10.0% 20.0% 30.0% 40.0% 50.0% 60.0% 70.0% 80.0% 2 Equity Markets Overview December 2012 Healthcare & 160 Life Sciences Industry Stock Performance 140 34.8% 29.3% 24.8% 120 100 80 60 40 Nov-09 Feb-10 May-10 Aug-10 Nov-10 Feb-11 May-11 Aug-11 Nov-11 Feb-12 May-12 Aug-12 Nov-12 S&P 500 Dow Jones U.S Health Care Index HW&Co. HCLS Index Top 25 Equity Gross Proceeds Closing Date Filing Date Issuer Ticker Transaction Type ($mm) Offerings 11/20/12 11/20/12 Neurocrine Biosciences Inc NBIX Follow-On $150.0 (by proceeds) 11/02/12 11/02/12 NuPathe Inc PATH Follow-On 145.2 11/09/12 11/23/11 Array Biopharma Inc ARRY Follow-On 75.6 11/16/12 10/01/12 Cynosure Inc CYNO Follow-On 75.4 11/06/12 11/06/12 Enanta Pharmaceuticals Inc ENTA IPO 69.0 11/08/12 11/08/12 Achillion Pharmaceuticals Inc ACHN Follow-On 50.0 11/30/12 11/14/12 Supernus Pharmaceuticals Inc SUPN Follow-On 48.0 11/13/12 05/09/12 MAKO Surgical Corp MAKO Follow-On 46.0 11/16/12 11/16/12 Patheon Inc PTI Follow-On 30.0 11/27/12 01/31/12 BioDelivery Sciences Intl Inc BDSI Follow-On 28.6 11/04/12 11/04/12 MEI Pharma Inc MEIP Follow-On 27.5 11/08/12 11/08/12 Anthera Pharmaceuticals Inc ANTH Follow-On 25.0 11/26/12 11/26/12 Chelsea Therpeutics Intl Ltd CHTP Follow-On 20.0 11/02/12 11/02/12 Lpath Inc LPTN Follow-On 20.0 11/30/12 11/30/12 Kips Bay Medical Inc KIPS Follow-On 18.2 11/27/12 11/27/12 Arno Therapeutics Inc LRRI Convertible 12.7 11/13/12 11/13/12 Arrayit Diagnostics Inc NA IPO 10.8 11/20/12 11/20/12 Novelos Therapeutics Inc NVLT Follow-On 10.0 11/27/12 11/27/12 TherapeuticsMD Inc TXMD Follow-On 7.1 11/09/12 11/09/12 Idera Pharmaceuticals Inc IDP Convertible 7.0 11/29/12 06/22/11 Rexahn Pharmaceuticals Inc RNN Follow-On 6.6 11/13/12 11/13/12 Advaxis Inc ADXS Follow-On 4.3 11/16/12 05/13/11 AspenBio Pharma Inc APPY Follow-On 4.1 11/07/12 02/13/12 Atossa Genetics Inc ATOS IPO 4.0 11/21/12 11/21/12 TrovaGene Inc TROV Follow-On 3.8 3 M&A Overview December 2012 Announced Quarterly M&A Activity Middle Market Healthcare Transaction Highlights 350 Healthcare & Announced Target Buyer 11/28/2012 Healthpoint, Ltd. Smith & Nephew plc Life Sciences 300 11/8/2012 Fortitech, Inc. Royal DSM N.V. 17 18 11/14/2012 Arcadia Solutions, LLC Ferrer Freeman & Company, LLC 16 11/8/2012 EpiCept Corporation Immune Pharmaceuticals Ltd. M&A __ 18 19 11/8/2012 Vessix Vascular, Inc. Boston Scientific Corporation 250 13 13 18 20 11/6/2012 Harbor Health Systems, LLC One Call Care Management, Inc. 17 11 12 11/6/2012 Sage Products, Inc. Madison Dearborn Partners, LLC 11/5/2012 Heartland Dental Care, Inc. Teachers' Private Capital 200 12 11/5/2012 Milliman Care Guidelines LLC The Hearst Corporation 11/1/2012 Nurse On Call, Inc. Emeritus Corp. 150 278 279 267 255 256 242 245 236 LTM Deal Statistics 225 229 221 Number Number Transactionsof 219 Aggregate Number Median Transaction Multiples 100 187 Value ($bn) of Deals TEV/Rev TEV/EBITDA $112.2 984 2.19x 11.0x 50 Note: Transactions based on publicly available information 0 4Q09 1Q10 2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12 2Q12 3Q12 4Q12 PEG Acquirer Strategic Acquirer Healthcare & Announced Healthcare & Life Sciences Transactions Median Healthcare & Life Sciences Transaction Multiples Life Sciences $500 1400 21x 4.0x M&A Trends $450 1200 18x 3.5x $400 $389.4 EV /LTM EV Revenue Multiple Number Number Transactionsof __ 1000 15.5x 15.2x 3.0x $350 15x $300 12.8x 2.5x 800 11.1x 12x 11.0x $250 2.0x $194.1 600 9x $200 7.7x $174.6 1.5x $141.4 $150 $110.6 400 6x 1.0x $100 $99.0 __ 200 __ EV /LTM EV EBITDA Multiple 3x $50 0.5x AggregateTransaction Value in($ billions) $0 0 0x 0.0x 2007 2008 2009 2010 2011 2012 YTD 2007 2008 2009 2010 2011 2012 YTD Aggregate Deal Value # of deals TEV / LTM EBITDA TEV / LTM Sales Announced PEG Investments by Segment (Last 3 Years) PEG Investments and Exits Private Equity HC&LS Industry Number of 140 Segment Companies 124 M&A Activity 120 Biotechnology 5 120 113 Healthcare Technology 19 ' Healthcare Distributors 9 100 94 95 Healthcare Equipment 24 79 80 Healthcare Facilities 36 80 69 71 Healthcare Services 62 65 62 Healthcare Supplies 8 58 60 60 55 Life Sciences Tools & Services 11 TransactionVolume 49 50 Managed Healthcare 6 40 40 42 40 Pharmaceuticals 19 31 27 23 20 0 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 YTD Number of Investments Number of Exits 4 Debt Markets Overview December 2012 Key Credit Quarterly Healthcare Loan Volume Average Spread on Healthcare Loans $24 Statistics L + 500 ___ $21 __ L + 400 $18 $15 L + 300 $12 $9 L + 200 $6 Average Spread Over LIBOR Over Spread Average L + 100 $3 Loan VolumeLoan
Load more

Recommended publications
  • Hospitals Hungry Under Health Reform
    20120924-NEWS--0001-NAT-CCI-CD_-- 9/21/2012 6:41 PM Page 1 ® www.crainsdetroit.com Vol. 28, No. 40 SEPTEMBER 24 – 30, 2012 $2 a copy; $59 a year ©Entire contents copyright 2012 by Crain Communications Inc. All rights reserved Page 3 Bills aim to African violence Hospitals hungry under touches auto supply chain flow funds health to sewer Electronics retailer unplugs Michigan search reform projects Inside New loan, grant Tom Henderson on how Systems prowl not to save Belle Isle, for acquisitions programs sought Page 4 BY CHAD HALCOM BY AMY LANE Crain’s Lists CRAIN’S DETROIT BUSINESS SPECIAL TO CRAIN’S DETROIT BUSINESS The need for efficiency under Communities may get some help Largest IT companies, health care reform may be lead- JEFF JOHNSTON/CDB from Lansing in managing and im- ing to a wave of consolidation and proving one of the most critical largest architectural firms, the possible entry of more for- people covered by Medicaid and and costly pieces of their infra- Pages 18, 19 profit health care companies into those newly insured in 2014. structure — their aging sewer sys- Michigan. Other changes under reform in- tems. Crain’s reported Sept. 16 that clude hospitals working with On the move in the Legislature This Just In Beaumont Health System has been physicians and other providers to are bills that would take about $654 approached by for-profits Van- contract as accountable care or- million remaining from a $1 billion ganizations. ACOs have the po- environmental bond passed by vot- 2 area defense contractors guard Health Systems Inc.
    [Show full text]
  • Update from the CEO by Charles Jaffe, MD, Phd, HL7 CEO HL7’S 22Nd Annual Plenary Meeting
    AUGUST 2008 In This Issue... Update from the CEO By Charles Jaffe, MD, PhD, HL7 CEO HL7’s 22nd Annual Plenary Meeting..... 2 Work Group Co-Chair Elections: As the languid days of August almost impercep- Development Organizations What to Expect in Vancouver................ 3 tibly transform into the cool autumn nights of (SDOs). Most importantly, September, some significant milestones emerged Update from Headquarters.............. 4-5 it is a living document. The from the HL7 landscape. Roadmap development team ExL Pharma’s 4th Annual EHR and will continue to be com- Charles Jaffe, MD, PhD eClinical Technologies Conference....... 6 The membership of HL7 has its very first posed of a broad constitu- News from the PMO.............................. 6 Roadmap. A strategic plan for technical and busi- ency with distinct requirements, and with plans to ness development is embodied in this document. It publish Roadmap updates annually. Version 3 Normative Edition 2008 Now Available...................................... 7 is more than just a promise to our stakeholders; the Roadmap provides the end-user community, gov- As the Roadmap matures, it will reflect the changing Multiple Modes of Delivering ernment agencies, software developers and other Education............................................. 8 business needs of our organization. More opportuni- standards development organizations clear guide- ties require more creative resource development and Advisory Council News....................... 9 lines for our products and services. In addition, the new means of expanding our funding model. Co-Chair Election Results.................... 9 Roadmap offers something beyond a commitment to develop a new standard or a new release of a Part of our new funding model emerged with the HL7 Certification Exam balloted one.
    [Show full text]
  • Federal Register/Vol. 63, No. 75/Monday, April 20, 1998/Notices
    Federal Register / Vol. 63, No. 75 / Monday, April 20, 1998 / Notices 19495 advice, pursuant to § 225.28(b)(9) of FEDERAL TRADE COMMISSION 7A(b)(2) of the Act permits the agencies, Regulation Y. in individual cases, to terminate this Granting of Request for Early Board of Governors of the Federal Reserve waiting period prior to its expiration Termination of the Waiting Period System, April 15, 1998. and requires that notice of this action be under the Premerger Notification Rules published in the Federal Register. Jennifer J. Johnson, The following transactions were Deputy Secretary of the Board. Section 7A of the Clayton Act, 15 granted early termination of the waiting [FR Doc. 98±10367 Filed 4±17±98; 8:45 am] U.S.C. 18a, as added by Title II of the period provided by law and the BILLING CODE 6210±01±F Hart-Scott-Rodino Antitrust premerger notification rules. The grants Improvements Act of 1976, requires were made by the Federal Trade persons contemplating certain mergers Commission and the Assistant Attorney or acquisitions to give the Federal Trade General for the Antitrust Division of the Commission and the Assistant Attorney Department of Justice. Neither agency General advance notice and to wait intends to take any action with respect designated periods before to these proposed acquisitions during consummation of such plans. Section the applicable waiting period. TRANSACTION GRANTED EARLY TERMINATION ET date Trans. No. ET req status Party name 30±MAR±98 ........................ 19981991 G Mr. Francois Pinault. G Brylane Inc. G Brylane Inc. 19982054 G Metropolitan Life Insurance Company. G Jay L.
    [Show full text]
  • Assessing Responses to Increased Provider Consolidation in Three Markets: Detroit, Syracuse, and Northern Virginia
    Assessing Responses to Increased Provider Consolidation in Three Markets: Detroit, Syracuse, and Northern Virginia By Sabrina Corlette, Jack Hoadley, Katie Keith, and Olivia Hoppe November 2018 Table of Contents Introduction and Approach . 1 Conclusion . 4. Case Study: Detroit . 5 . Case Study: Syracuse . 10. Case Study: Northern Virginia . 16 . Acknowledgments . .22 . Assessing Responses to Increased Provider Consolidation Introduction and Approach Rising health care prices have increased concerns Insurers—under pressure from employer purchasers and about hospital and health system consolidation policymakers to keep costs affordable while maintaining among policymakers, regulators, employers, and other health care quality—are thus exploring a range of strategies purchasers of health coverage . Although merging to counter provider consolidation in their markets . The ability hospitals and health systems claim they can achieve to implement and successfully deploy these strategies can greater efficiencies through their consolidation, the vary significantly, depending on the market in which insurers economic literature almost universally finds that hospitals are operating . that merge have prices above those of surrounding In a series of six market-level, qualitative case studies, hospitals .1 More broadly, markets with increased levels we assess the impact of recent provider consolidations of provider concentration, regardless of the reason, tend and overall provider concentration, the ability of market to see higher prices .2 Indeed, increases in hospital prices participants (and, where relevant, regulators) to respond have been a key factor driving the growth of commercial to those consolidations, and effective strategies for health insurance costs over the past decade .3 constraining cost growth while maintaining clinical quality . As prices have risen, employers have shifted an ever Our case studies focus on the commercial insurance greater share of the costs to employees .
    [Show full text]
  • HL7 Mobile Health Work Group
    SEPTEMBER 2013 HL7 Mobile Health Work Group 101 By Gora Datta, Co-Chair, HL7 Mobile Health Work Group; Co-Lead, HL7 In- teroperability EHR Work Group; HL7 Ambassador; Group Chairman & CEO, CAL2CAL Corporation The HL7 Mobile Health (MH) Work Group is now • Identify and one year old! Over the past year, the work group promote mobile (WG) has rapidly matured from loosely held health concepts interested individuals to a cohesive group of ex- for interoper- perts that meets regularly. We welcome one and ability as Gora Datta all to join our Mobile Friday weekly calls every adopted and Friday at 11am ET. adapted for use in the mobile environment. • Coordinate and cooperate with other The group’s mission “The HL7 Mobile Health groups interested in using mobile health to Work Group creates and promotes health infor- promote health, wellness, public health, mation technology standards and frameworks for clinical, social media, and other settings. mobile health” captures the essence of its charter, • Provide a forum where HL7 members and as outlined: stakeholders collaborate in standardizing • Identify (and develop, as applicable) data to enable the secure exchange, storage, standards and functional requirements that analysis, and transmission of data and are specific to the mobile health environment. information for mobile applications and/ or mobile devices. One of the challenges the group has is that it is one of the few HL7 groups (like the EHR WG) that is not domain specific; and is more horizontal in nature. Therefore, its charter cuts across other vertical/domain oriented (work) groups. Given the tremendous interest and participation not only in the US but also globally, the HL7 Mobile Health WG is rapidly stepping up to identify and fill the gaps in the mobile health standards space.
    [Show full text]
  • Health Industry Business Communications Council
    Health Industry Business Communications Council Registered Labelers: Accredited Auto-ID Labeling Standards Argentina New MedTek Devices Pty Ltd Oxavita SRL Norseld Pty Ltd. Novadien Healthcare Pty Ltd The following companies Odontit S.A. (and/or their subsidiaries/ PAMPAMED S.R.L. Numedico Technologies Pty Ltd divisions) have applied PATEJIM SRL Opto Global Pty. Ltd. for a Labeler Identification Orthocell Limited Code (LIC) assignment with Austria Prolotus Technologies Pty Ltd HIBCC*. By doing so, they afreeze GmbH Red Milawa Pty Ltd dba Magic Mobility have demonstrated their AMI GmbH SDI Limited commitment to patient safety Bender Medsystems GmbH Signostics Ltd. and logistical efficiency for BHS Technologies GmbH Sirtex Medical Pty Ltd their customers, the industry Metasys Medizintechnik GmbH Smith & Nephew Surgical Pty. Ltd. and the public at large. PAA Laboratories GmbH Staminalift International Limited Safersonic Medizinprodukte Handels The Pipette Company Pty. Ltd. Any organization that is GmbH Thermo Electron Corporation interested in using the HIBC W & H Dentalwerk Burmoos GmbH Vush Pty Ltd uniform labeling system may apply for the assignment of VUSH STIMULATION Australia one or more LICs. William A Cook Australia Pty. Ltd. Adv. Surgical Design & Manufacture, Ltd. Last updated 9-21-2021 AirPhysio Pty Ltd Belgium Annalise-AI Pty Ltd 3M Europe Apollo Medical Imaging Technology Pty Advanced Medical Diagnostics SA/NV Ltd Analis SA/NV Benra Pty Ltd dba Gelflex Laboratories Baxter World Trade Bioclone Australia Pty. Ltd. Bio-Rad RSL Candelis, Inc. Bio-Rad Lab Inc Clinical Diag. Group DePuy Australia Pty. Ltd. Biosource Europe SA For more information, please dorsaVi Ltd Cilag NV contact the HIBCC office at: EC Certification Service GmbH Coris Bioconcept Fink Engineering Pty Ltd Fuji Hunt Photographic Chemicals NV 2525 E.
    [Show full text]
  • Itdothealth II the Meeting at Harvard on a Health Information Technology Platform
    ITdotHealth II The Meeting at Harvard on a Health Information Technology Platform SEPTEMBER 10-11, 2012 COUNTWAY LIBRARY OF MEDICINE MINOT ROOM, 5TH FLOOR 10 SHATTUCK ST. BOSTON, MA 02115 S: Agenda Monday, September 10, 2012 11:00am Lunch, Networking Ballard/Lahey Rooms 1:00pm Introduction Minot Room Kenneth Mandl Director, Intelligent Health Lab, Boston Children’s Hospital Infor- matics Program; Associate Professor, Harvard Medical School 1:15pm Making EHR Apps Substitutable: Theory & Experience Minot Room Joshua Mandel Lead Architect, SMART Platforms; Research Faculty, Boston Chil- dren’s Hospital Informatics Program; Instructor, Harvard Medical School 1:45pm Apps & APIs: Innovating With and Around Vendor and Homegrown EHRs Minot Room Moderator: Brian Athey Chair, University of Michigan Medical School, Depart- ment of Computational Medicine and Bioinformatics; Professor, UM Med- ical School Howard Goldberg Senior Corporate Manager, Partners Health Care; Lecturer, Har- vard Medical School John Halamka Chief Information Officer, Beth Israel Deaconess Medical Center; Co-Chair, National Health IT Standards Committee; Professor, Harvard Medical School John Hutton Director of Biomedical Informatics, Cincinnati Children’s Hospital; Professor, University of Cincinnati College of Medicine John Mattison Chief Medical Information Officer, Kaiser Permanente 3:00pm Keynote Address: “Data, Predictions, and Decisions: On Computational Futures Minot room for Evidence-Based Healthcare” Eric Horvitz Distinguished Scientist & Deputy Managing Director,
    [Show full text]
  • Internship Positions Nationwide
    Internship Positions Nationwide Some Potential Internships found online (Paid and Unpaid) Google https://www.google.com/about/careers/students/business-internships/ Pepsi Co. http://www.pepsicojobs.com/campus_recruiting Procter & Gamble http://us.pgcareers.com/students/internships-co-ops/ Nordstrom http://about.nordstrom.com/careers/#/student-center/main Major League Baseball http://chicago.cubs.mlb.com/mlb/help/jobs.jsp?c_id=chc Nike http://jobs.nike.com/article/internships Apple http://www.apple.com/jobs/us/students.html Microsoft https://careers.microsoft.com/students/internships Viacom http://www.viacomcareers.com/internships.html National Football League http://www.nfl.com/careers/internships Caterpillar http://www.caterpillar.com/en/careers/career-areas/college/unitedstates/intern- program.html Fortune 500 Internship Programs 1) Exxon Mobil http://www.exxonmobil.com/USA-English/HR/careers_campus.aspx 2) Wal-Mart Stores https://jobs.walmart.com/us/jobs?keywords=Internship&page=1 3) Chevron http://careers.chevron.com/students/internship_programs/default.aspx 4) ConocoPhillips http://careers.conocophillips.com/university-recruitment/ 5) General Motors http://careers.gm.com/student-center.html 6) General Electric http://talent.gecareers.com/university 7) Berkshire Hathaway https://www.bhhc.com/careers/career-opportunities/internship-opportunities.aspx 8) Fannie Mae http://fanniemae.com/portal/careers/students.html 9) Ford Motor https://corporate.ford.com/careers/students-and-recent-grads.html 10) Hewlett-Packard http://www8.hp.com/us/en/jobsathp/students-graduates/programs/internship- opportunities.html 11) AT&T http://att.jobs/careers/college 12) Valero Energy https://www.valero.com/en-us/Careers 13) Bank of America Corp. https://campus.bankofamerica.com/ 14) McKesson http://www.mckesson.com/en_us/McKesson.com/Careers/Campus%2BRecruiting/Interns.html 15) Verizon Communications http://www22.verizon.com/jobs/campus.html 16) J.P.
    [Show full text]
  • I4i Makes the Patent World Blind Michael J
    COMMENTS i4i Makes the Patent World Blind Michael J. Conway† All patents receive a presumption of validity pursuant to 35 USC § 282. Courts have traditionally put this presumption into practice by requiring inva- lidity to be established by clear and convincing evidence. The Supreme Court reaffirmed this understanding of the presumption in Microsoft Corp v i4i Ltd Partnership. District courts have divided, however, on whether to require clear and con- vincing evidence when the challenger seeks to invalidate a patent for covering inel- igible subject matter. The conflict originates from a concurrence written by Justice Stephen Breyer in i4i, in which he stated that a heightened standard of proof—like the clear and convincing standard—can apply only to issues of fact, not issues of law. Because subject-matter eligibility has traditionally presented an issue of law, some courts hold that subject-matter-eligibility challenges cannot be subjected to the clear and convincing standard. Other courts agree with that sentiment but would apply the clear and convincing standard to resolve any underlying issues of fact. Still others maintain that subject-matter-eligibility challenges must be estab- lished by clear and convincing evidence. This Comment resolves this ambiguity by showing that subject-matter- eligibility challenges must be established by clear and convincing evidence. It com- pares subject-matter-eligibility challenges to two other patent validity challenges: the on-sale bar and nonobviousness. These two comparisons show that patent law has consistently failed to confine the clear and convincing standard to issues of law. In fact, the standard has been imposed without regard for the distinction be- tween issues of law and fact.
    [Show full text]
  • THOMAS F. FRIST, JR., MD in First Person
    THOMAS F. FRIST, JR., M.D. In First Person: An Oral History American Hospital Association Center for Hospital and Healthcare Administration History and Health Research & Educational Trust 2013 HOSPITAL ADMINISTRATION ORAL HISTORY COLLECTION THOMAS F. FRIST, JR., M.D. In First Person: An Oral History Interviewed by Kim M. Garber On January 17, 2013 Edited by Kim M. Garber Sponsored by American Hospital Association Center for Hospital and Healthcare Administration History and Health Research & Educational Trust Chicago, Illinois 2013 ©2013 by the American Hospital Association All rights reserved. Manufactured in the United States of America Coordinated by Center for Hospital and Healthcare Administration History AHA Resource Center American Hospital Association 155 North Wacker Drive Chicago, Illinois 60606 Transcription by Chris D‘Amico Photos courtesy of the Frist family, HCA, the American Hospital Association, Louis Fabian Bachrach, Micael-Renee Lifestyle Portraiture, Simon James Photography, and the United Way of Metropolitan Nashville EDITED TRANSCRIPT Interviewed in Nashville, Tennessee KIM GARBER: Today is Thursday, January 17, 2013. My name is Kim Garber, and I will be interviewing Dr. Thomas Frist, Jr., chairman emeritus of HCA Holdings, Inc. In the 1960s, together with his father, Dr. Thomas Frist, Sr., Dr. Frist conceived of a company that would own or manage multiple hospitals, providing high quality care and leveraging economies of scale. Founded in 1968, the Hospital Corporation of America, now known as HCA, has owned or managed hundreds of hospitals. Known as the First Family of Nashville, the Frists have made substantial contributions to Music City through their work with the Frist Foundations and other initiatives.
    [Show full text]
  • Healthcare & Life Sciences Industry Update
    Healthcare & Life Sciences Industry Update August 2011 Member FINRA/SIPC www.harriswilliams.com What We’ve Been Reading August 2011 • The biggest story from inside the Beltway over the last month was the battle and eventual deal to raise the U.S. debt ceiling to avoid an impending August 2nd default. The Budget Control Act of 2011 will raise the debt ceiling by $2.1-$2.4 trillion, while reducing spending by approximately $2.1 trillion over the next decade. In an interesting post-deal analysis, Michael Hiltzik of the Los Angeles Times notes that despite the protracted negotiations over a broad spectrum of cost-cutting measures, healthcare was not raised as a primary issue. Some have found this especially concerning, considering the outsized portion of the Federal Budget currently allocated to healthcare spending, which is forecast to rise in the coming years. A recent article in The Economist, entitled “Looking to Uncle Sam” makes this point and goes further to suggest that Centers for Medicare & Medicaid Services (CMS) actuaries may be underestimating future increases in Medicare and Medicaid spending. • One potential reason CMS actuaries may be underestimating the future costs of Medicare and Medicaid relates to healthcare reform’s effect on employee benefits, and specifically, the 2014 switch to subsidized exchange policies. A recent report by McKinsey & Company estimates that approximately 30% of employers will stop offering employer- sponsored insurance (ESI) when this switch is made, as opposed to the 7% estimated by the Congressional Budget Office. An ESI exodus of this magnitude could cause substantial strain on an already robust government healthcare budget.
    [Show full text]
  • Seven Members Honored HL7 Honored Seven Members with the 14Th Annual W
    JANUARY 2011 Upcoming WORKING GROUP MEETINGS 2010 Ed Hammond Volunteer of the Year Awards Seven members honored HL7 honored seven members with the 14th annual W. Edward Hammond, PhD Volunteer of the Year Award. Established in 1997, the award is named after Dr. Ed Hammond, one of HL7’s most active volunteers, founding member and past Board chair. The award recognizes individuals who January 9 – 14, 2011 May 15 – 20, 2011 have made significant contributions to HL7’s success. The 2010 recipients include: • Hugh Glover and Julie James, HL7 UK January Working Group • Stan Huff, MD, chief medical informatics officer, Intermountain Healthcare Working Group Meeting • Charlie Mead, MD, MSc, CTO, 3rd Millennium, Inc. Meeting • Mark Shafarman, principal, Shafarman Consulting Hilton in the Walt Disney World Resort • D. Mead Walker, Health Data and Interoperability, Inc. Cliftons Meeting and Training Center Lake Buena Vista, FL • Pat Van Dyke, director of information, security, privacy and EDI representing Delta Dental and the Amora Hotel Plans Association Sydney, Australia About the Volunteers: Hugh Glover and Julie James have been involved with HL7 since 2001. They received the award jointly as they are partners both personally and profession- ally. They have both actively contributed to HL7 for many years and have held leadership positions in the Pharmacy Work Group such as a co-chair or facili- tator. Their backgrounds—James as a pharmacist and Glover’s expertise in data modeling—complement each other and have brought valuable insight to HL7. Both have been involved with Version 3 development since its inception. James September 11 – 16, 2011 January 15 – 20, 2012 is also active in the Patient Safety Work Group.
    [Show full text]